V5 antibody and other epitope tag antibodies: choosing a tag and its reagent

Tagging is the way out of the antibody problem. Instead of finding a reagent that recognises your protein, you attach a short sequence that an extremely well characterised reagent already recognises, and every experiment afterwards uses the same validated antibody. The decisions that remain are which tag, where to put it and how many copies, and each of those can break the protein rather than the detection.

one validated tag antibody serves every tagged construct in the laboratory
1 reagent
the authentication guidance a funded study is expected to follow
NIH rigor
the FDA labelling clause behind research use only on the vial
809.10

Figures in this panel are the practical consequence of tagging and the authentication and labelling rules a research reagent is used under, linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.

Choosing the tag and placing it

  1. Understand what the tag buys. One reagent, validated once, works on every tagged construct in the laboratory, in every application, with a known negative control in the untagged parent. That reproducibility is worth more than almost any improvement in an antibody against the native protein.
  2. Choose between the common tags on practical grounds. The short tags differ mainly in length, charge and which reagents are best characterised for which application. Where two tags are needed on different proteins in one experiment, choose ones whose antibodies are raised in different hosts so the secondaries do not collide.
  3. Decide the terminus from the protein's biology. A tag at a terminus that carries a signal sequence, a localisation signal or a processing site will disrupt it. Check both termini against what is known about the protein, and if neither is safe, an internal tag in a flexible loop is the alternative.
  4. Use multiple copies when signal is the problem, and expect a cost. Repeating the tag increases the signal proportionally and increases the chance of interfering with folding, trafficking or interactions. Start with one copy and add only if detection genuinely fails.
  5. Prove the tagged protein still behaves. Localisation, molecular weight, an activity assay and, where possible, rescue of the untagged protein's function. A tagged construct that has not been shown to behave like the original is a new protein you are now studying.

Tagging the endogenous locus rather than overexpressing

Knocking a tag into the native locus by genome editing keeps expression at physiological level and under native regulation, which removes the overexpression artefacts that plague transfected constructs. It costs an editing project and is usually worth it for a protein you will study for years.

It also gives an exact control: the parental line is the untagged negative, isogenic in every other respect, which is the cleanest specificity control available for any detection method.

Using a His tag antibody for purification as well as detection

Several tags have matched affinity resins, so the same construct serves detection, immunoprecipitation and purification. Elution by competition with free peptide is gentle and expensive; low pH elution is cheap and harsher on the protein.

Where the tag is used for purification, plan how and whether it is removed. A protease site between the tag and the protein is designed in at the start or it is not available later.

Multiplexing two tagged proteins

Use tags whose antibodies come from different host species, and cross-adsorbed secondaries. Two tags detected by antibodies from the same host require sequential detection and a blocking step, with its own controls.

Record which tag is on which construct in the plasmid map and in the cell line record. Tag confusion between two constructs in the same freezer is a recurring and entirely avoidable experiment lost.

A tag antibody may also see the endogenous protein, as a protein C antibody can

Several common tags are derived from real proteins, so an antibody raised against the tag can also detect the endogenous version in the same sample. Where that protein is expressed, an untransfected control is what separates the tagged band from it, and without one a construct can appear to be expressed when it is not.

This is most confusing when the tag's parent protein is itself a common target, because a catalogue search returns reagents for both uses under similar names. Read the immunogen: an antibody against a short tag peptide and an antibody against the full protein are different products.

Fragment formats where size matters

Removing the constant region gives a smaller reagent that penetrates dense tissue better and does not engage receptors that bind whole immunoglobulin. That removes a real class of background in tissue with high receptor content, and it costs avidity, so it is a trade to make deliberately rather than by default.

Fragments are also used to avoid a secondary reagent binding the wrong immunoglobulin in a multiplex stain, and to label a primary directly. In both cases the conjugation chemistry and the formulation matter, which is why carrier-free material is specified for this work.

Single domain binders and how to detect them

Single domain binders derived from camelid immunoglobulin are small, stable and increasingly common as research reagents, and ordinary anti-species secondaries do not detect them. Detection needs either a reagent raised against that format or a tag engineered onto the binder itself.

Check host reactivity before ordering, because a reagent against the format may also bind conventional immunoglobulin from the same species. In a sample containing both, that turns a clean detection into an ambiguous one, and it is easy to miss on a product page.

Where a polyclonal is still the better reagent

A polyclonal binds several epitopes on its target, which gives sensitivity for scarce proteins, robustness when one epitope is masked or modified, and tolerance of fixation conditions that would abolish a single-epitope reagent. For a first attempt at a difficult target it is frequently the one that works.

Its cost is lot variability: a new lot is a new mixture and may behave differently. Buy enough of a working lot for the project where the budget allows, record the lot with every result, and move to a recombinant reagent once the assay is routine.

An avi tag, and what enzymatic biotinylation buys

The AviTag is a fifteen residue sequence that biotin ligase biotinylates on one specific lysine, which gives a protein exactly one biotin in a known place. That is the difference from chemical biotinylation, which labels several lysines at random and changes activity unpredictably. Site-specific labelling is what surface plasmon resonance, single molecule work and clean streptavidin capture need. The practical requirements are the ligase, either co-expressed or added in vitro, free biotin and ATP, and a check that the tag was actually modified.

Common questions

Why use a V5 tag antibody instead of one against my protein?
Because the reagent is already characterised and the same one works for every tagged construct. You also get a clean negative control for free in the untagged parent line, which is the hardest control to obtain otherwise.
Which tag should I choose, an HA tag antibody or a Myc tag antibody?
Any of the well established short tags will do for detection. Choose on practical grounds: antibody host species where you need to multiplex, whether the tag's charge or length is likely to matter, and which reagents your laboratory already has validated.
Amino or carboxy terminus for a FLAG tag antibody?
Whichever does not disrupt a signal sequence, a localisation signal, a processing site or a domain boundary. If both are problematic, an internal site in a flexible loop is worth trying, though it needs more validation.
Does tagging change the protein, and will a Strep tag II antibody still bind?
Sometimes, and that is why the control experiments matter. Show that the tagged protein localises correctly, runs at the expected size and retains function before trusting any result from it.
Why does my tag antibody give a band in untransfected cells?
Because several common tags come from real proteins, and the antibody sees the endogenous version too. Run an untransfected control in every experiment so the tagged band can be told apart from it.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/epitope-tag-antibodies/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices